Related Experiment Video
Updated: Nov 2, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
G protein-coupled receptors can control the Hippo/YAP pathway through Gq signaling
Diana Zindel1, Patrick Mensat2, Claire Vol1
1Institut de Génomique Fonctionnelle (IGF), Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Abstract:
The Hippo pathway is an evolutionarily conserved kinase cascade involved in the control of tissue homeostasis, cellular differentiation, proliferation, and organ size, and is regulated by cell-cell contact, apical cell polarity, and mechanical signals. Miss-regulation of this pathway can lead to cancer. The Hippo pathway acts through the inhibition of the transcriptional coactivators YAP and TAZ through phosphorylation. Among the various signaling mechanisms controlling the hippo pathway, activation of G12/13 by G protein-coupled receptors (GPCR) recently emerged. Here we show that a GPCR, the ghrelin receptor, that activates several types of G proteins, including G12/13, Gi/o, and Gq, can activate YAP through Gq/11 exclusively, independently of G12/13. We revealed that a strong basal YAP activation results from the high constitutive activity of this receptor, which can be further increased upon agonist activation. Thus, acting on ghrelin receptor allowed to modulate up-and-down YAP activity, as activating the receptor increased YAP activity and blocking constitutive activity reduced YAP activity. Our results demonstrate that GPCRs can be used as molecular switches to finely up- or down-regulate YAP activity through a pure Gq pathway.
Insights
The ghrelin receptor activates YAP, a key protein in organ size control, exclusively through the Gq pathway, not G12/13. This discovery offers a novel way to modulate YAP activity for potential therapeutic applications.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- The Hippo pathway regulates organ size and tissue homeostasis.
- Dysregulation of the Hippo pathway is linked to cancer.
- G protein-coupled receptors (GPCRs) are increasingly recognized as regulators of the Hippo pathway.
Purpose of the Study:
- To investigate the role of the ghrelin receptor, a GPCR, in activating the Hippo pathway.
- To determine the specific G protein signaling pathways involved in ghrelin receptor-mediated YAP activation.
- To explore the potential of targeting the ghrelin receptor for modulating YAP activity.
Main Methods:
- Utilized cell-based assays to study GPCR signaling.
- Investigated the activation of YAP and TAZ transcriptional coactivators.
- Examined the role of different G protein subtypes (G12/13, Gi/o, Gq) in mediating ghrelin receptor effects.
- Assessed the impact of ghrelin receptor agonists and antagonists on YAP activity.
Main Results:
- The ghrelin receptor activates YAP exclusively through the Gq/11 pathway, independent of G12/13.
- A high basal activity of the ghrelin receptor leads to significant YAP activation.
- Activating the ghrelin receptor increases YAP activity, while blocking its constitutive activity decreases YAP activity.
- GPCRs can function as molecular switches to precisely control YAP activity.
Conclusions:
- The ghrelin receptor acts as a specific Gq-coupled activator of YAP.
- Targeting the ghrelin receptor offers a novel strategy for modulating YAP activity in a controlled manner.
- This finding has implications for understanding tissue homeostasis and developing cancer therapies.
Related Concept Videos
IP3/DAG Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Hedgehog Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

